Efficacy of Emapalumab, an Anti-IFNγ Antibody in Patients with Macrophage Activation Syndrome (MAS) Complicating Systemic Juvenile Idiopathic Arthritis (sJIA) Who Had Failed High-Dose Glucocorticoids (GCs)

Showing live article 1121 of 1309 in channel 80318369
Article Details:

Author:
Language: English
Channel Number: 80318369
Article Number: 1121
Date: October 19, 2021, 9:00 am
URL: https://acrabstracts.org/abstract/efficacy-of-emapalumab-an-anti-ifn%ce%b3-antibody-in-patients-with-macrophage-activation-syndrome-mas-complicating-systemic-juvenile-idiopathic-arthritis-sjia-who-had-failed-high-dose-glucocortic/
GUID: https://acrabstracts.org/abstract/efficacy-of-emapalumab-an-anti-ifn%ce%b3-antibody-in-patients-with-macrophage-activation-syndrome-mas-complicating-systemic-juvenile-idiopathic-arthritis-sjia-who-had-failed-high-dose-glucocortic/